View Older Stories View More Recent Stories
-
Aon plc (AON) Added to Goldman Director's Cut US Conviction List
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris International (PM) Tops Q2 EPS by 5c, Misses on Revenue; offers FY25 EPS Guidance
-
Philp Morris earnings preview Q2: stronger print expected on smoke-free portfolio gains
-
Philip Morris (PM) PT Raised to $200 at Goldman Sachs
-
Philip Morris (PM) PT Raised to $181 at UBS
-
Philip Morris (PM) PT Raised to $200 at Citi
-
Jefferies Starts Philip Morris (PM) at Buy
-
BofA's momentum indicator lists top-ranked stocks globally
-
Goldman rolls out latest U.S. Conviction List update
-
Stifel on Philip Morris (PM): 'We come away from the meetings with a positive bias toward PMI’s developing multi-category approach'
-
Philip Morris International (PM) Declares $1.35 Quarterly Dividend; 2.9% Yield
-
UBS Reiterates Neutral Rating on Philip Morris (PM)
-
Philip Morris (PM) PT Raised to $200 at BofA Securities
-
Philip Morris International (PM) reaffirms its 2025 full-year reported diluted EPS forecast
-
What stocks and implied dividends may indicate when it comes to recession risk
-
UBS upgrades Philip Morris on margin improvement at Zyn and IQOS
-
UBS Upgrades Philip Morris (PM) to Neutral
-
Philip Morris (PM) PT Raised to $186 at Stifel
-
Philip Morris International (PM) Tops Q1 EPS by 9c, Beats on Revenue
-
Philip Morris International (PM) call put ratio 3.7 calls to 1 put with a focus on May 165 calls into quarter results
-
Philip Morris International (PM) call put ratio 1.8 calls to 1 put into quarter results
-
Philip Morris (PM) PT Raised to $130 at UBS
-
Philip Morris International (PM) U.S. Launches IQOS
-
Philip Morris International (PM): Court Approves CCAA Plans to Resolve Tobacco Product-Related Claims and Litigation in Canada
-
Philip Morris International (PM) reaffirms its 2025 full-year reported diluted EPS forecast
-
Philip Morris (PM) PT Raised to $163 at Citi
-
Philip Morris (PM) PT Raised to $160 at Stifel
-
Stifel Out Positive on Philip Morris (PM) Following Earnings, 'FY25 Profit Outlook Above Medium-Term Targets'
-
Philip Morris International (PM) Misses Q4 EPS by 1c
-
Philip Morris International (PM) call put ratio 3.4 calls to 1 put with a focus on February 7 weekly calls into quarter results
-
Menthol Cigarette Ban Withdrawn By Trump Administration - Bloomberg
-
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
-
FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review
-
Morgan Stanley Starts Philip Morris (PM) at Overweight
-
FDA Proposes Significant Step Toward Reducing Nicotine to Minimally or Nonaddictive Level in Cigarettes and Certain Other Combusted Tobacco Products
-
Increasing unusual call option volume: MO PM FREY QUBT KULR WCC RGTI TTE FHN
-
F.D.A. Tries Last-Ditch Move to Slash Nicotine Levels in Cigarettes - NYT
-
Philip Morris (PM) PT Raised to $155 at Barclays
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris International (PM) Tops Q3 EPS by 9c, Beats on Revenue
-
Philip Morris International (PM) call put ratio 2 calls to 1 put into quarter results
-
Philip Morris International (PM) call put ratio 2.7 calls to 1 put into quarter results
-
Philip Morris International (PM) call put ratio 3.1 calls to 1 put with focus on January 130 calls
-
Philip Morris (PM) PT Raised to $135 at Deutsche Bank
-
Philip Morris (PM) PT Raised to $140 at Goldman Sachs
-
BofA Securities Defending Philip Morris (PM), 'remains top pick in US tobacco', Shares down ~2.5%
-
Philip Morris' (PM) Vectura Fertin Pharma tp Sell Vectura Group to Molex for GBP 150M Cash
-
Philip Morris International (PM) Raises Quarterly Dividend 3.8% to $1.35; 4.3% Yield
